Boston, MA. March 17, 2005 - Morgenthaler (www.morgenthaler.com), a leading national venture capital and management buyout firm, announced today the opening of its new Boston office. Jim Broderick and Daniel Farrar, two of the firm's general partners, will be based at the new location. "The steady increase in quality life science opportunities in the Northeast has made this decision a natural one," said Jim Broderick, M.D. and a general partner focused on the biopharmaceutical, medical device, and health-care services sectors. Broderick relocated to Boston from Menlo Park, CA, where Morgenthaler's venture capital group is headquartered. According to Broderick, Morgenthaler has been active in life science investments for more than two decades. Its current life science investment focus includes minimally invasive and implantable medical devices, as well as, multi-product biopharmaceutical platforms. Current portfolio companies in life sciences include biotech companies Threshold Pharmaceuticals, Replidyne, Bayhill Therapeutics, GlobeImmune, OncoMed, and Trellis Bioscience, medical device companies Thermage, Satiety, Xtent, and Spine Wave, and services companies IPC and Third Millennium. Daniel Farrar, a Morgenthaler general partner focused on middle-market management buyouts, joined the firm last year after heading a $5-billion financial-services division of General Electric. "Our focus is sharp and our activity level is high," said Farrar. "Having a Morgenthaler buyout presence on the East Coast will add to that momentum," he said. According to Farrar, Morgenthaler's buyout team closed 5 deals in 11 months. They plan to leverage their leadership in the manufacturing sector, specifically highly-engineered content and component manufacturing, and expand their reach in business and industrial services. Current buyout portfolio companies include: Precision Parts International (PPI), Formed Fiber, GED Integrated Solutions, Comm-Works, Inc, UAV, and Phillips and Temro. This new office expands upon Morgenthaler's current East Coast venture capital team led by Greg Blonder, Morgenthaler's general partner in New Jersey, and Paul Levine, Morgenthaler's venture partner who has been operating successfully out of Boston for the last five years. Both Blonder and Levine are focused on venture-stage information technology investments. Morgenthaler's Boston office is located at 545 Boylston Street, 9th Floor, Boston, MA, 02116. The firm's current East Coast portfolio companies include: ETI (http://www.extrutech.com), FONS Corporation (http://www.fons.com), Formed Fiber (http://www.formedfiber.com), Lamina Ceramics (www.laminaceramics.com); NanoOpto (www.nanoopto.com), Neothermia (www.neothermia.com), Overture Networks (www.overturenetworks.com), Paratek (www.paratek.com), Sionex Corp (www.sionex.com), SpineWave, StarGen Technologies (www.stargen.com), Third Millennium, Wave7 Optics (www.wave7optics.com), and UAV Corporation (www.uavco.com). About Morgenthaler Morgenthaler is a leading national venture capital and management
buyout firm with offices in Boston, MA; Boulder, CO; Cleveland, OH;
Menlo Park, CA; and Princeton, NJ. Its venture capital team - consisting
of 11 general partners - focuses on life sciences and information
technology investments. Its management-buyout team - consisting of 9
general partners, associates, and managers - focuses on investments in
highly-engineered content and component manufacturing, as well as,
business and industrial services. About Jim Broderick:
http://www.morgenthaler.com/ventures/team_member.asp?id=24 ### |